17/01/2006 (Agence Europe) - In a press release dated 12 January, the Swiss laboratory, Roche, announced it would launch a new technology transfer initiative for the production of saquinavir. Under this initiative, Roche gives up its rights on the patents that it holds on the process for manufacturing this HIV protease inhibitor medicine, and announces it will expand its current activities with sub-Saharan Africa and the world's Least Developed Countries by providing local manufacturers with...